On ECHEMI
Home > Drugs > Chengdu Shengnuo Biopharm Co., Ltd.
Chengdu Shengnuo Biopharm Co., Ltd.
  • Founded in:

    2004-10-12
  • Country:

    China China
  • Address:

    Section 1, Gongye Avenue, Dayi County, Chengdu
  • Tax NO.:

    9151012976229886XR
  • Registered Funds:

    50 million yuan
  • Website:

  • Email:

Related Drugs
Thymopentin for injection
The main ingredient of this product is thymopentin.
Name Description Content CAS NO. Registered Holders
Thymopentin

Immune bidirectional regulatory drug. It has the function of inducing and promoting the differentiation, maturation and activation of T lymphocytes and their subgroups, regulating the ratio of T lymphocytes to make CD4/CD8 tend to normal; regulating and enhancing the cellular immune function of the human body, which can promote the maturation of T lymphocytes in peripheral blood after mitogen activation, increase the secretion of various lymphokines (such as alpha, gamma interferon, interleukin 2 or interleukin 3) after T cells are activated by various antigens or mitogens, and increase the level of lymphokine receptors on T cells. It also enhances lymphocyte response by activating T helper cells. In addition, this product may affect the chemotaxis of NK precursor cells, which become more cytotoxic after exposure to interferon, which is conducive to its therapeutic effect. In addition, this product can enhance the body's ability to resist radiation.

More

Immune bidirectional regulatory drug. It has the function of inducing and promoting the differentiation, maturation and activation of T lymphocytes and their subgroups, regulating the ratio of T lymphocytes to make CD4/CD8 tend to normal; regulating and enhancing the cellular immune function of the human body, which can promote the maturation of T lymphocytes in peripheral blood after mitogen activation, increase the secretion of various lymphokines (such as alpha, gamma interferon, interleukin 2 or interleukin 3) after T cells are activated by various antigens or mitogens, and increase the level of lymphokine receptors on T cells. It also enhances lymphocyte response by activating T helper cells. In addition, this product may affect the chemotaxis of NK precursor cells, which become more cytotoxic after exposure to interferon, which is conducive to its therapeutic effect. In addition, this product can enhance the body's ability to resist radiation.

69558-55-0 41
Octreotide Acetate Injection
Name Description Content CAS NO. Registered Holders
Octreotide acetate

Extract from the above information

More

Extract from the above information

83150-76-9 44
Octreotide acetate
Name Description Content CAS NO. Registered Holders
Octreotide acetate

Extract from the above information

More

Extract from the above information

83150-76-9 44
Thymus alpha-sin for injection
Name Description Content CAS NO. Registered Holders
Thymalfasin

Extracting pharmacological effects from the above information

More

Extracting pharmacological effects from the above information

69440-99-9 14
Thymus alpha
Name Description Content CAS NO. Registered Holders
Thymalfasin

69440-99-9 14
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.